AAAAAA

   
Results: 1-9 |
Results: 9
Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C
Authors: Recasens, M Aguilera, E Ampurdanes, S Tapias, JMS Simo, O Casamitjana, R Conget, I
Citation: M. Recasens et al., Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C, DIABET MED, 18(9), 2001, pp. 764-767
High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis
Authors: Gimenez-Barcons, M Franco, S Suarez, Y Forns, X Ampurdanes, S Puig-Basagoiti, F Sanchez-Fueyo, A Barrera, JM Llovet, JM Bruix, J Sanchez-Tapias, JM Rodes, J Saiz, JC
Citation: M. Gimenez-barcons et al., High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis, HEPATOLOGY, 34(1), 2001, pp. 158-167
Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center
Authors: Forns, X Ampurdanes, S Sanchez-Tapias, JM Guilera, M Sans, M Sanchez-Fueyo, A Quinto, L Joya, P Bruguera, M Rodes, J
Citation: X. Forns et al., Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center, J HEPATOL, 35(2), 2001, pp. 265-271
Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C
Authors: Puig-Basagoiti, F Saiz, JC Forns, X Ampurdanes, S Gimenez-Barcons, M Franco, S Sanchez-Fueyo, A Costa, J Sanchez-Tapias, JM Rodes, J
Citation: F. Puig-basagoiti et al., Influence of the genetic heterogeneity of the ISDR and PePHD regions of hepatitis C virus on the response to interferon therapy in chronic hepatitis C, J MED VIROL, 65(1), 2001, pp. 35-44
Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C
Authors: Guilera, M Forns, X Torras, X Enriquez, J Coll, S Sola, R Morillas, R Planas, R Ampurdanes, S Soler, M Costa, J Saiz, JC Sanchez-Tapias, JM Rodes, J
Citation: M. Guilera et al., Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C, J HEPATOL, 33(1), 2000, pp. 135-141
Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressure
Authors: Gimenez-Barcons, M Sanchez-Fueyo, A Ampurdanes, S Puig-Basagoiti, F Guilera, M Ibanez, A Clotet, B Martinez, MA Rodes, J Saiz, JC Sanchez-Tapias, JM
Citation: M. Gimenez-barcons et al., Genetic evolution of GB virus C/hepatitis G virus (GBV-C/HGV) under interferon pressure, ANTIVIR RES, 46(2), 2000, pp. 157-170
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon
Authors: Lopez-Labrador, FX Ampurdanes, S Gimenez-Barcons, M Guilera, M Costa, J de Anta, MTJ Sanchez-Tapias, JM Rodes, J Saiz, JC
Citation: Fx. Lopez-labrador et al., Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon, HEPATOLOGY, 29(3), 1999, pp. 897-903
Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases
Authors: Gimenez-Barcons, M Forns, X Ampurdanes, S Guilera, M Soler, M Soguero, C Sanchez-Fueyo, A Mas, A Bruix, J Sanchez-Tapias, JM Rodes, J Saiz, JC
Citation: M. Gimenez-barcons et al., Infection with a novel human DNA virus (TTV) has no pathogenic significance in patients with liver diseases, J HEPATOL, 30(6), 1999, pp. 1028-1034
Comparative study of a modified competitive RT-PCR and Amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum
Authors: Olmedo, E Costa, J Lopez-Labrador, FX Forns, X Ampurdanes, S Maluenda, MD Guilera, M Sanchez-Tapias, JM Rodes, J de Anta, MTJ
Citation: E. Olmedo et al., Comparative study of a modified competitive RT-PCR and Amplicor HCV monitor assays for quantitation of hepatitis C virus RNA in serum, J MED VIROL, 58(1), 1999, pp. 35-43
Risultati: 1-9 |